BioMime Vs. Xience Randomised Control Clinical Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 256 participants.
Also called NCT02112981
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 256 participants
- Registry
-
NCT02112981 -
2013-005353-67
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Belgium, Brazil, Czechia, Latvia, Netherlands, North Macedonia, Poland, Spain, United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT02112981. Randomized; no masking; primary purpose treatment. Start 2014-11-05 (actual); primary completion 2017-09-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BioMime Vs. Xience Randomised Control Clinical Study
- Acronym
- meriT-V
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Sirolimus Eluting Coronary Stent
- Intervention (Device)
- Everolimus-eluting Coronary stent
- Lead sponsor
- Meril Life Sciences Pvt. Ltd.
Record details
- Record id
cardio:ct-nct02112981- Content hash
297aedd4742197b08c058eb92333647f8ae1e6c7eb84ed4d09125022c881ca9f